D
Celldex Therapeutics, Inc. CLDX
$21.75 -$0.18-0.82% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -56.60M -53.80M -47.09M -42.12M -35.84M
Total Depreciation and Amortization 873.00K 867.00K 819.00K 786.00K 797.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.51M 7.05M 6.42M 5.29M 2.90M
Change in Net Operating Assets 4.22M -8.50M 7.38M -19.29M 2.82M
Cash from Operations -44.01M -54.37M -32.48M -55.34M -29.33M
Capital Expenditure -728.00K -265.00K -756.00K -545.00K -274.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 50.58M 43.22M 24.80M 48.30M -46.45M
Cash from Investing 49.85M 42.95M 24.05M 47.76M -46.72M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 63.00K 202.00K 386.00K 1.24M 3.71M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 63.00K 202.00K 386.00K 1.24M 3.71M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 5.91M -11.22M -8.04M -6.34M -72.34M